Completed EARLY_PHASE1 INTERVENTIONAL 3-arm NCT01083095

Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers (ChallengeII)

Sponsor: Malaria Vaccine and Drug Development Center

Interventions Sporozoite Challenge Model for Plasmodium vivax in Humans

Updated 8 times since 2017 Last updated: Mar 8, 2010 Started: Jan 31, 2005 Primary completion: Mar 31, 2005 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01083095, this EARLY_PHASE1 trial focuses on Malaria, Vivax and remains completed. Sponsored by Malaria Vaccine and Drug Development Center, it has been updated 8 times since 2005, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Nov 2025 — Present [monthly]

Completed EARLY_PHASE1
Sep 2025 — Nov 2025 [monthly]

Completed EARLY_PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Malaria Vaccine and Drug Development Center
Ministerio de la Protección Social, Colombia.

Data source: Malaria Vaccine and Drug Development Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cali, Colombia